Pharmaniaga to manufacture Sinovac Covid-19 vaccine starting March

KUALA LUMPUR: Pharmaniaga Bhd has the capacity to manufacture two million doses of COVID-19 vaccine developed by Sinovac Life Sciences Co Ltd per month beginning March this year.

Group managing director Datuk Zulkarnain Md Eusope said the vaccine would be the first to be manufactured in Malaysia at the small volume injectable high-tech plant owned by Pharmaniaga's wholly-owned subsidiary, Pharmaniaga LifeSciences Sdn Bhd, in Puchong.